Showing results (231-240 of 683) with videos related to
Sort By:
Pageof 69
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|April 1, 1991
Immune dysfunction in multiple myeloma. Reduced natural killer cell activity and increased levels of soluble interleukin-2 receptorsH Nielsen, H J Nielsen, N Tvede, et al.Ugeskrift for Laeger|November 27, 1989
[Herpes zoster in immunosuppressed patients with immuno-inflammatory disease]M Schou, V AndersenAlimentary Pharmacology & Therapeutics|June 4, 2014
Systematic review: interactions between aspirin, and other nonsteroidal anti-inflammatory drugs, and polymorphisms in relation to colorectal cancerV Andersen, U VogelJournal of Immunological Methods|January 1, 1977
A method for autoradiographic studies of single clones of plaque forming cellsV Andersen, I LefkovitsNordisk Medicin|September 1, 1996
[Copper in the drinking water--cause of gastrointestinal symptoms?]V Andersen, P JoffeAllergy|April 1, 1978
Cell-mediated immunity of Yersinia enterocolitica serotype 3 in patients with thyroid diseasesK Bech, O Clemmensen, J H Larsen, et al.Scandinavian Journal of Immunology|September 1, 1975
Cell-mediated immunity to a serologically defined (SD) HL-A antigen panel in kidney-transplanted patientsG Bendixen, E Dickmeiss, A Svejgaard, et al.Cancer Immunology, Immunotherapy : CII|January 1, 1990
The effect of ranitidine on cellular immunity in patients with multiple myelomaH J Nielsen, H Nielsen, F Moesgaard, et al.Autoimmunity|January 1, 1992
Anti-diabetogenic effect of fusidic acid in diabetes prone BB ratsK Buschard, C Pedersen, S V Hansen, et al.Neurology|November 30, 2000
Neutralizing antibodies to interferon (IFN) alpha-2a and IFN beta-1a or IFN beta-1b in MS are not cross-reactiveK M Myhr, C Ross, H I Nyland, et al.Pageof 69